1. Kim J, Choi SC, Kim TH, Kim KD, Cho SY, Park SS, & Lee SH. Isolation of neuronal precursors from differentiating P19 embryonal carcinoma cells by neuronal T alpha 1-promoter-driven GFP. International Journal of Developmental Neuroscience 19:631-638.
2. Kim J, Wu HH, Lander AD, Lyons KM, Matzuk MM, & Calof AL. GDF11 controls the timing of progenitor cell competence in developing retina. Science 308:1927-1930.
3. Kim J, Krishnaswami SR, & Gleeson JG. CEP290 interacts with the centriolar satellite component PCM-1 and is required for Rab8 localization to the primary cilium. Human Molecular Genetics 17:3796-3805.
4. Kawauchi S*, Kim J*, Santos R, Wu HH, Lander AD, & Calof AL. Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11. Development 136:1453-1464.
5. Beites CL*, Hollenbeck PL*, Kim J*, Lovell-Badge R, Lander AD, & Calof AL. Follistatin modulates a BMP autoregulatory loop to control the size and patterning of sensory domains in the developing tongue. Development 136:2187-2197.
6. Kim J, Lee JE, Heynen S, Suyama E, Ono K, Lee KY, Ideker T, Aza-Blanc P, & Gleeson JG. Functional genomic screen for modulators of ciliogenesis and cilium length. Nature 464:1048-1051.
7. Jo H & Kim J. Itinerary of vesicles to primary cilia. Animal Cells Systems 17:221-227.
8. Joo K, Kim CG, Lee MS, Moon HY, Lee SH, Kim MJ, Kweon HS, Park WY, Kim CH, Gleeson JG, & Kim J. CCDC41 is required for ciliary vesicle docking to the mother centriole. Proceedings of the National Academy of Sciences 110:5987-5992.
9. Kim J, Jo H, Hong H, Kim MH, Kim JM, Lee JK, Heo WD, & Kim J. Actin remodeling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking. Nature Communications 6:6781.
10. Hong H, Kim J, & Kim J. Myosin heavy chain 10 (MYH10) is required for centriole migration during the biogenesis of primary cilia. Biochemistry Biophysics Research Communications 461:180-185.
11. Kim MH, Kim J, Hong H, Lee SH, Lee JK, Jung E, & Kim J. Actin Remodeling Confers BRAF Inhibitor Resistance to Melanoma Cells through YAP/TAZ Activation. EMBO Journal 35:462-478.
12. Lee SH, Lee MS, Choi TI, Hong H, Seo JY, Kim CH, & Kim J. MCRS1 associates with cytoplasmic dynein and mediates pericentrosomal material recruitment. Scientific Reports 6:27284.
13. Kim M, Suh YA, Oh JH, Lee BR, Kim J, & Jang SJ. KIF3A binds to β-arrestin for suppressing Wnt signalling independently of primary cilia in lung cancer. Scientific Reports 6:32770.
14. Kim MH & Kim J. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cellular and Molecular Life Science 74:1457-1474.
15. Lee SH, Joo K, Jung E, Hong H, Seo J, & Kim J. Export of membrane proteins from the Golgi complex to the primary cilium requires the kinesin motor, KIFC1. FASEB Journal 32:957-968.
16. Seo J & Kim J. Regulation of Hippo signaling by actin remodeling. BMB Repports 51:151-156.
17. Kim MH, Kim CG, Kim SK, Shin SJ, Choe EA, Park SH, Shin EC, & Kim J. YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma. Cancer Immunology Research 6:255-266.
18. Kim YJ, Kim S, Jung Y, Jung E, Kwon HJ, & Kim J. Eupatilin rescues ciliary transition zone defects to ameliorate ciliopathy-related phenotypes. Journal of Clinical Investigation 128:3642-3648.
19. Hong H, Joo K, Park SM, Seo J, Kim MH, Shin E, Cheong HI, Lee JH, & Kim J. Extraciliary roles of the ciliopathy protein JBTS17 in mitosis and neurogenesis. Annuls of Neurology 86:99-115.
20. Kim YJ, & Kim J. Therapeutic perspectives for structural and functional abnormalities of cilia. Cellular and Molecular Life Science 76:3695-3709.
21. Seo J, Kim MH, Hong H, Cho H, Park S, Kim SK, & Kim J. MK5 regulates YAP stability and is a molecular target in YAP-driven cancers. Cancer Research 79:6139-6152.
22. Jung E, Choi EI, Lee, JE, Kim CH, & Kim J. ESCRT subunit CHMP4B localizes to primary cilia and is required for the structural integrity of the ciliary membrane. FASEB Journal 34:1331-1344.
23. Kim BH, Kim YJ, Kim MH, Na YR, Jung D, Seok SH, Kim J, & Kim HJ. Identification of FES as a novel radiosensitizing target in human cancers. Clinical Cancer Research 26:265-273.
24. Kim YJ, Jung E, Shin E, Hong SH, Jeong HS, Hur G, Jeong HY, Lee SH, Lee JE, Kim GW, & Kim J. Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation. Proceedings of the National Academy of Sciences 117:19994-20003.
25. Shin E & Kim J. The potential role of YAP in head and neck squamous cell carcinoma. Experimental Molecular Medicine 52:1264-1274.
26. Seo J, Kim H, Min KI, Kim C, Kwon Y, Zheng Z, Kim Y, Park HS, Ju YS, Roh MR, Chung KY, & Kim J. Weight-bearing activity impairs nuclear membrane and genome integrity via YAP activation in plantar melanoma. Nature Communications 13: 2214.
27. Shin E, Kwon Y, Jung E, Kim YJ, Kim C, Hong S, & Kim J. TM4SF19 controls GABP-dependent YAP transcription in head and neck cancer under oxidative stress conditions. Proceedings of the National Academy of Sciences 13;121(7):e2314346121.
28. Park S, Ryu W, Kim TY, Hwang Y, Han HJ, Lee JD, Kim GM, Sohn J, Kim SK, Kim MW, & Kim J. Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation. Experimental Molecular Medicine 56: 987-1000.
29. Kim C, Hong S, M SH, Lee J, So H, Kim JY, Shin E, Lee K, Choia S, Park J, Park JK, Kim YM, Kim JH, & Kim J. Replication stress-induced nuclear hypertrophy alters chromatin topology and impacts cancer cell fitness. Proceedings of the National Academy of Sciences 122: e2424709122.